GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » EPS (Basic)

Hubei Guangji Pharmaceutical Co (SZSE:000952) EPS (Basic) : ¥-0.80 (TTM As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co EPS (Basic)?

Hubei Guangji Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥-0.10. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.80.

Hubei Guangji Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥-0.10. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.80.

Hubei Guangji Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥-0.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.73.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hubei Guangji Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 239.10% per year. The lowest was -59.30% per year. And the median was -24.80% per year.


Hubei Guangji Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co EPS (Basic) Chart

Hubei Guangji Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.32 0.14 -0.40 -0.84

Hubei Guangji Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.16 -0.15 -0.39 -0.10

Hubei Guangji Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hubei Guangji Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-295.291-0)/351.872
=-0.84

Hubei Guangji Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-36.266-0)/349.722
=-0.10

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hubei Guangji Pharmaceutical Co  (SZSE:000952) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Hubei Guangji Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Guangji Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 555, Huaihai West Road, 26th Floor, Xuhui District, Shanghai, CHN, 200030
Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.
Executives
Zou Guang Ming Independent director
Guo Shao Zhi Executives
Zhang Bin Director
Guo Wen Chao Supervisors
Sun Zhen Hua Director
Liao Qing Jiang Director
Wang Xin Directors, executives
Hu Feng Lei Supervisors
Ruan Zhong Yi Executives
Zhang Ping Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines